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ABSTRACT
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The loss of estrogens at menopause significantly increases a woman’s risk of memory
loss and Alzheimer’s disease because estrogens are essential trophic factors for the
hippocampus. However, current hormone replacement therapies are not recommended
to reduce age-related memory decline because of their adverse side effects. To
develop better hormone replacement therapies, it is essential to understand the
mechanisms through which estrogens regulate memory. Our laboratory has
demonstrated that the ability of 17β-estradiol (E2) to enhance hippocampal memory
depends on the rapid activation of extracellular-signal-regulated kinase (ERK), which
occurs through activation of ERα and ERβ. The G-protein coupled estrogen receptor
(GPER) is a novel membrane estrogen receptor, expressed in areas of the brain
important for learning and memory such as the hippocampus. However, little is
known about the role of dorsal hippocampal (DH) GPER in hippocampal memory
consolidation and cell signaling. Here, the present study tested the roles of GPER in
regulating hippocampal memory consolidation and cell signaling in young female
mice. DH infusion of the GPER agonist, G-1, enhanced object recognition and spatial
memory consolidation in ovariectomized female mice. DH infusion of the GPER
antagonist, G-15, blocked the memory-enhancing effects of G-1, suggesting that
ii

GPER activation mimics the beneficial effects of E2 on hippocampal memory.
Interestingly, however, G-1 did not increase ERK phosphorylation like E2, but instead
significantly increased phosphorylation of the c-Jun N-terminal kinase (JNK) in the
DH, suggesting that the molecular mechanisms underlying the memory-enhancing
effects of GPER activation may differ from those of ERα and ERβ activation.
Consistent with this notion, DH infusion of the JNK inhibitor, SP600125, blocked G1-induced memory enhancement and JNK phosphorylation, whereas the ERK
inhibitor, U0126, did not. Finally, we showed that DH infusion of SP600125 or G-15
did not prevent E2 from enhancing memory and activating ERK, demonstrating that
the memory-enhancing effects of E2 are not dependent on JNK or GPER activation in
the DH. These results indicate that GPER regulates memory independently from ERα
and ERβ by activating JNK signaling, rather than ERK signaling. Together, the data
suggest that GPER does not function as an estrogen receptor in the DH. As such, this
study identifies GPER as a putative new target for reducing memory decline in
menopausal women without the detrimental side effects of currently available
treatment options
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Introduction
The massive loss of estrogens at menopause significantly increases the risk of
memory deficiency and Alzheimer’s disease (AD) in women (Zandi et al., 2002; Yaffe
et al., 2007). Out of the 5.2 million Alzheimer’s disease patients, 3.4 million are
women (Alzheimer's Association, 2012), and this number will continue to increase
due to the aging of the baby boomer generation. In 2012, the costs of patient care for
AD and other dementias is estimated at $200 billion and are projected to rise to $1.1
trillion by 2050 (Alzheimer's Association, 2012). Estrogen therapies can decrease the
risk of menopause-related memory decline and AD in women (Yaffe et al., 1998;
Zandi et al., 2002), however these treatments are accompanied by increased risk of
breast cancer, heart disease, and stroke (Rossouw et al., 2002). The effects of
estrogens in the hippocampus are important to study because hippocampus
dysfunction leads to memory loss (deToledo-Morrell et al., 1988). Unfortunately, the
mechanisms underlying the beneficial effects of estrogens on memory are not fully
understood. These beneficial effects may be mediated by intracellular estrogen
receptors (ERα and ERβ) or membrane-bound ERs (e.g., G-protein coupled estrogen
receptor; GPER) (Waters et al., 2011). Although some evidence suggests an important
role of intracellular ERs (ERα and ERβ) in memory formation (Liu et al., 2008; Frick
et al., 2010b; Boulware et al., 2013), very little is known regarding the role of GPER
in hippocampal memory consolidation.
This gap in our knowledge is important to address because manipulating
GPER could provide the memory-enhancing effects of intracellular ER activation
without cancerous side effects, as ERα and ERβ activation are implicated in certain
types of cancer (Deroo and Korach, 2006; Burns and Korach, 2012). Whereas nuclear
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ERα and ERβ expression increased or stayed constant during breast cancer
progression (Filardo et al., 2006), GPER expression decreased, and other evidence
suggests that GPER acts independently from ERα and ERβ in cancer cell lines
(Filardo and Thomas, 2012). Furthermore, GPER activation suppresses cell
proliferation in ovarian cancer cell lines (Ignatov et al., 2013). Therefore,
understanding the role of GPER in estrogen signaling may help resolve some of the
controversies related to estrogen’s involvement in regulating both cognitive function
and certain types of cancer. Moreover, better understanding of GPER function could
also provide important opportunities for the development of new therapies that would
provide the cognitive benefits of estrogens while limiting potentially dangerous side
effects.

Hippocampus
The hippocampus is one of the most researched structures in the brain. It is a
bilateral medial temporal lobe structure that plays a central role in the functioning of
the limbic system, due to its connections with the temporal cortex (e.g., entorhinal,
perirhinal, and parahippocampal cortices), septum, and amygdala (Arushanyan and
Beier, 2008). The primary cell type within the hippocampus is the pyramidal neuron,
which are organized into a form of three-layered cortical tissue. The hippocampus in
subdivided into several subregions, denoted as CA1, CA2, CA3, and dentate gyrus,
based on morphologic and functional composition. Although the specific functions of
the hippocampus remain subject to debate, most investigators agree that the
hippocampus plays a critical role in learning and memory.
The famous case study of patient H.M, firstly published by Brenda Milner,
first suggested the critical importance of the hippocampus for memory formation
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(Scoville and Milner, 1957). After surgery of a bilateral medial temporal lobectomy,
H.M. had severely impaired memory, although not all types of memory were affected.
H.M. experienced severely impaired declarative memory; H.M. had severe
anterograde amnesia as well as partial retrograde amnesia, on the other hand, His
nondeclarative memory and short-term memory was preserved (Corkin et al., 1997).
Therefore, H.M. study demonstrated the organization of memory in the brain, long
term memory and immediate memory and the findings from H.M. motivated the
efforts to study the neurobiological mechanisms underlying memory formation in
animal models, such as monkey and rodent models (Squire, 2009). Two of the most
well-known functions of the hippocampus are the generation of cognitive maps for
use in spatial navigation and regulating episodic memory processes (Smith and
Mizumori, 2006).

Analysis of neuronal activity, by recordings of single neurons in

the hippocampus, revealed that the hippocampus is involved in spatial navigation, as
well as other abilities including detecting speed and direction of movement, match or
non-match detection, and olfactory discrimination (Holscher, 2003).
To test functioning of hippocampus in rodent models, many behavioral tests
have been established. For example, spatial learning and memory can be evaluated
using several different methods, including the Morris water maze, Barnes maze, radial
arm maze, T-maze, and Y-maze (Yuede et al., 2007). Our laboratory uses object
recognition and object placement tasks to test hippocampal- dependent object
recognition memory and spatial memory because these one-trail tasks allow us to link
memory consolidation with rapid molecular events within the hippocampus.
Moreover, these tasks can be conducted using the same apparatus and training
procedures, permitting observation of multiple forms of hippocampal memory under
similar testing conditions.
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Object recognition (OR) and object placement (OP)
OR and OP have ben used extensively to examine hippocampal memory in
rodents because they are sensitive to numerous factors, including hormones, aging,
and drug treatments (Tuscher et al., 2014). Although the tasks can be run with
anywhere from 2-6 objects, most protocols for rodents typically require them to
explore two identical objects in a testing arena. During the training phase, these two
objects are usually identical.

For object recognition, memory is tested after a delay

by allowing subjects to explore one familiar object that is identical to the training
objects and one novel object. Mice who remember the familiar object will spend more
time than chance exploring the novel object. For object placement, memory is tested
by moving one of the familiar training objects to a new location in the arena. Mice
who remember the training object locations will spend more time than chance
exploring the moved object.
Both OR and OP are well suited for investigating hormonal regulation of
hippocampal memory because these tasks take advantage of rodent's instinct,
attraction to novel stimuli, without other potential variables influencing motivation.
For example, the Morris water maze involves the stress of submersion in water and
dry land mazes like the radial arm maze, T-maze, and Y-maze involve the stress of
nutrient restriction. These stressors can induce physiological changes, including
hormone level changes that can differ between males and females (ter Horst et al.,
2012). In contrast, OR and OP involve only the subject’s own intrinsic motivation to
explore; it uses no nutrient restriction, provides no rewards, and it does not place
subjects in an uncomfortable stressful environment (i.e., no water submersion, shock,
or exposure to bright light). Therefore, OR and OP are ideal behavior tasks for
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studying the effects of hormone treatment on learning and memory. Despite some
controversy surrounding the role of the hippocampus in object recognition, several
studies demonstrate the importance of the hippocampus in regulating object
recognition (Clark et al., 2000; Broadbent et al., 2004). In fact, one recent study
suggests that inactivation of a very small portion of the total hippocampus can impair
object recognition memory (Cohen et al., 2013). Furthermore, ovariectomy impairs
memory in both OR and OP (Wallace et al., 2006), and as will be demonstrated below,
estrogen treatment enhances OR and OP memory consolidation.

Estrogen effects on the hippocampus
Estrogens are a class of sex steroid hormones that are synthesized primarily
within the ovaries and placenta, although smaller amounts of estrogens are also
synthesized in non-gonadal organs such as the heart, liver, bone, and muscle (Cui et
al., 2013). Estrogens influence many physiological processes via estrogen receptors
(ERs), including reproduction, bone integrity, cognition, and parenting behaviors. The
three major forms of estrogens are estrone (E1), estradiol (E2), and estriol (E3). Of
these, E2 is most potent and biologically active. E2 levels in the rat hippocampus are
higher than in serum (Hojo et al., 2004), implying an important role of estrogens in
the hippocampus. The earliest findings to demonstrate that E2 regulates hippocampal
function showed that dendritic spine density in the CA1 region in the female rat
hippocampus is elevated when estrogen levels are their highest during the estrous
cycle and that E2 treatment reverses an ovariectomy-induced decrease in CA1 spine
synapse density (Gould et al., 1990; Woolley et al., 1990). Exogenous E2 also
increases hippocampal neurogenesis and enhances various forms of hippocampal
synaptic plasticity, including long-term potentiation (Foy et al., 1999; McClure et al.,
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2013). In general, estrogens have been shown to enhance hippocampal memory in
menopausal women and female rodents (Duff and Hampson, 2000; Frick, 2009).
Many studies have demonstrated that exogenous E2 administration enhances
hippocampal memory using a variety of tasks, including the Morris water maze, radial
arm maze, and T-maze (Bimonte and Denenberg, 1999; Daniel and Dohanich, 2001;
Wide et al., 2004; Bohacek and Daniel, 2007). As discussed below and in our recent
review (Tuscher et al., 2014), E2 facilitates memory consolidation in the OR and OP
tasks as well. However, the molecular mechanisms underlying this enhancement are
not well understood.
Using an ovariectomized mouse model, our laboratory previously
demonstrated that post-training bilateral infusion of E2 into the dorsal hippocampus
(DH) enhances hippocampal-dependent memory consolidation in the OR task
(Fernandez et al., 2008). Other work from our lab has shown that DH E2 infusions
also enhance hippocampal-dependent spatial memory in OP (Boulware et al., 2013).
Although the role of the hippocampus in OR has been subject to debate (Gervais et al.,
2013), DH lesions or inactivations demonstrate that the DH is essential for object
recognition memory consolidation in rats and mice (Clark et al., 2000; Baker and Kim,
2002; Fernandez et al., 2008; Cohen et al., 2013). In our laboratory, E2 is infused
immediately after training in OR and OP, rather than before training, to pinpoint E2’s
effects on memory consolidation without affecting motivation, anxiety, or encoding
during training. Infusion of E2 three hours after training does not enhance memory
consolidation (Fernandez et al., 2008), suggesting that E2-induced hippocampal
memory consolidation occurs within three hours of training. Vehicle-infused young
ovariectomized mice show a significant preference for the novel object 24 hr, but not
48 hr, after OR training. However, E2-infused mice exhibit enhanced memory 48 hr
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after OR training, as indicated by their spending significantly more time than chance
with the novel object. For the OP task, vehicle-infused young ovariectomized mice
show a significant preference for the moved object 4 hr, but not 24 hr, after OP
training. However, E2-infused mice exhibit a significant preference for the moved
object 24 hr after OP training. Thus, to test the memory-enhancing effects of drugs,
we use a 48-hr retention delay for OR and a 24-hr delay for OP. To test the memoryimpairing effects of drugs, we use a 24-hr delay for OR and a 4-hr delay for OP.
Our laboratory has extensively studied the molecular mechanisms through
which E2 affects hippocampal memory (Harburger et al., 2007; Lewis et al., 2008;
Pechenino and Frick, 2009; Fan et al., 2010; Frick et al., 2010a; Zhao et al., 2010;
Zhao et al., 2012; Boulware et al., 2013; Fortress et al., 2013b; Fortress et al., 2013a;
Fortress et al., 2014). In particular, we have shown repeatedly that phosphorylation of
the p42 isoform of the cell signaling kinase extracellular signal regulated kinase (ERK)
in the DH is necessary for E2 to enhance OR memory (Fernandez et al., 2008; Fan et
al., 2010; Zhao et al., 2010; Zhao et al., 2012). This activation is observed as early as
five minutes after DH infusion of E2. The importance of ERK in mediating the
mnemonic effects of E2 was underscored by other work from our laboratory showing
that rapid activation of the p42 isoform of ERK (p42-ERK) is required for histone
acetylation alterations that promote the transcriptional events that enhance memory
consolidation (Zhao et al., 2010). Although this work sheds light on the intracellular
events that underlie the memory-enhancing effects of E2, the ERs that mediate these
effects have remained somewhat of a mystery.

Estrogen receptors
Two types of ERs, intracellular ERs (ERα and ERβ) and membrane ERs (e.g.,
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GPER, ER-X) likely mediate the memory-enhancing effects of E2. The intracellular
ERs, ERα and ERβ, have been cloned and are found in several brain regions
including the hippocampus of the nuclei, dendritic spines, and axon terminals of
pyramidal neurons and interneurons (Milner et al., 2001; Milner et al., 2005). When
estrogens bind to ERα or ERβ in the cytoplasm, they are dimerized and move into the
nucleus where they bind to estrogen response elements (ERE) to initiate gene
transcription (Cheskis et al., 2007). This so-called classic nuclear action of estrogens
is considered somewhat slow because the cellular effects can take hours to be
observed. However, ERα and ERβ can also activate hippocampal cell signaling
cascades within minutes, suggesting an alternative mechanism of action. Such rapid
effects have been termed “non-classical” mechanisms. One established non-classical
mechanism regulating involves interactions between ERα and ERβ and metabotropic
glutamate receptors (mGluR) to stimulate the phosphorylation of the transcription
factor cAMP response element-binding protein (CREB) (Boulware et al., 2005).
Although studies using ERα and ERβ knockout mice have suggested that the effects
of E2 on hippocampal memory are dependent on ERβ, but not ERα (Liu et al., 2008;
Walf et al., 2008), potential compensatory mechanisms after gene knockout
throughout early development make it difficult to pinpoint the roles of each
intracellular ER. Therefore, ERα-selective and ERβ-selective agonists have been
developed to differentiate the role of each ER to memory formation.
Recently, our laboratory used ER agonists to show that the intracellular
estrogen receptors ERα and ERβ can mediate the E2-induced enhancement of object
recognition and object placement memory consolidation (Boulware et al., 2013).
Specifically, bilateral infusion of propyl pyrazole triol (PPT, ERα agonist) or
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diarylpropionitrile (DPN, ERβ agonist) into the DH immediately after OR or OP
testing enhanced object recognition and object placement memory consolidation. Like
E2, both PPT and DPN increased phosphorylation of the p42, but not the p44, isoform
of ERK 5 minutes after infusion, and this activation was necessary for PPT and DPN
to enhance memory. Because ERα and ERβ are not integral membrane proteins, it is
unlikely that they activate ERK on their own. Instead, we found that both receptors
must interact mGluR1 to rapidly activate ERK signaling and enhance memory
consolidation (Boulware et al., 2013).
As an alternative to intracellular receptors, E2 may regulate memory by
binding to membrane ERs (mERs). The existence of specific mERs has been the
subject of intensive debate in recent years because they have yet to be cloned.
Candidate mERs include G-protein coupled estrogen receptor 1 (GPER), ER-X, and
Gq-mER. Despite the uncertainty surrounding the identity of the mERs, these
receptors can be examined generally using bovine serum albumin (BSA)-conjugated
E2 (BSA-E2), which is membrane impermeable (Taguchi et al., 2004). Unlike E2,
BSA-E2 does not activate estrogen responsive gene transcription (Watters et al., 1997).
Instead, BSA-E2 rapidly activates calcium signaling and ERK phosphorylation in vitro
and in vivo (Carrer et al., 2003; Wu et al., 2011). In addition, our laboratory has found
that infusion of BSA-E2 into the DH of ovariectomized female mice enhances OR
memory consolidation in an ERK-dependent manner (Fernandez et al., 2008). These
effects were not blocked by an intracellular ER antagonist (ICI 182,780) (Fernandez
et al., 2008), suggesting that mER activation can influence memory and ERK
activation independently of intracellular ERs. Although informative, studies using
BSA-E2 do not provide information about which mERs are involved. Given the
difficulty of identifying these ERs, it is therefore, challenging to target them
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pharmacologically or genetically. However, the availability of agonist and antagonist
drugs for the recently named GPER had led to an increasing number of studies aimed
at understanding the role of this putative mER in memory formation.

G-Protein Coupled Estrogen Receptor 1 (GPER)
GPER is a G-protein coupled receptor, previously known as the orphan
GPCR called GPR30 (Funakoshi et al., 2006). Although has been considerable debate
about whether GPER is, indeed, a mER (Langer et al., 2010), there was sufficient
evidence from peripheral tissues that the receptor’s name was officially changed from
GPR30 to GPER. GPER is expressed at high levels in the brain, including the
hippocampus (Brailoiu et al., 2007). Within the hippocampus, GPER is localized
within dendritic spines of excitatory synapses and peri-synaptic regions in CA1
hippocampal neurons (Akama et al., 2013; Srivastava and Evans, 2013). GPER is a
seven transmembrane domain (7TMD) receptor that includes the heterotrimeric G
protein subunits Gαβγ (Filardo and Thomas, 2005). The Gα protein is involved in
regulating ion channels and membrane-associated enzymes, whereas the Gβγ-subunit
plays a role in activating protein kinase cascades (Luttrell et al., 1999; Filardo and
Thomas, 2005). Importantly, G proteins provide signaling mechanisms critical for the
regulation of different mitogen-activated protein kinase (MAPK) (Goldsmith and
Dhanasekaran, 2007). Some studies suggest that activation of the SRC-like tyrosine
kinase downstream of GPER can promote the induction of the MAPK pathway
(Maggiolini and Picard, 2010), and that both E2 and the GPER agonist G-1 increase
ERK phosphorylation in pancreatic beta cells (Sharma and Prossnitz, 2011). However,
other studies indicate that activation of GPER does not induce ERK phosphorylation
in human vascular smooth muscle cells (Ortmann et al., 2011) and that ERK
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inhibition has no effect on the ability of G-1 to induce DNA synthesis in human
epithelial cells (Holm et al., 2011). Several other downstream targets of GPER have
been characterized, including a SRC-like tyrosine kinase (Quinn et al., 2009), PKA
via cAMP (Thomas et al., 2005), PI3K/Akt (Maggiolini and Picard, 2010), and the
Notch signaling pathway (Ruiz-Palmero et al., 2011).
Interestingly, some reports have demonstrated that ERα localized at the
membrane interacts directly with various G-proteins (Wyckoff et al., 2001; Kumar et
al., 2007). However, potential interaction between GPER and intracellular ERs has
not been examined. As mentioned above, whether GPER is, in fact, an estrogen
receptor has been a matter of heated debate. Some investigators insist that GPER is
not a true ER, but potentially has a collaborative role in mediating the biological
actions of estrogens (Levin, 2009). Although this issue has not yet been resolved for
neural tissue, evidence in peripheral tissues suggests that GPER binds E2 with a high
affinity (Thomas et al., 2005), prompting the name change from GPR30 to GPER.
The contribution of GPER to hippocampal memory formation is not well
established. However, some pharmacological studies have examined the role of GPER
in memory processes using systemic injections of the GPER agonist, G-1, and
antagonist, G-15. G-1 is a selective agonist for GPER that does not bind ERα and
ERβ at concentrations up to 10 µM in vitro (Bologa et al., 2006; Blasko et al., 2009)
and G-15 is selective antagonist for GPER that also does not bind to ERα and ERβ at
concentrations up to 10 µM in vitro using COS7 cells (fibroblast-like cells) (Dennis et
al., 2009). One recent study showed that chronic systemic treatment with G-1 mimics
the beneficial effects of E2 on spatial working memory in young female rats
(Hammond et al., 2009). In contrast to G-1, systemic treatment with G-15 impairs
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spatial working memory in young female rats (Hammond and Gibbs, 2011). Although
these studies suggest that GPER regulates hippocampal memory, their use of systemic
injections do not permit definitive conclusions about the role of hippocampal GPER
in memory formation. To address this issue, this thesis employed direct DH infusions
of G-1 and G-15 to pinpoint the role of hippocampal GPER in memory consolidation.

c-Jun N-terminal kinase (JNK)
G-proteins like GPER can activate numerous cell-signaling cascades.

As

will be discussed below, our results led us to examine cascades other than ERK,
including the JNK signaling pathway. Like ERK, JNK belongs to the mitogenactivated protein kinase (MAPK) family and has a kinase signaling cascade structure
in which mitogen-activated protein kinase kinase (MKK) 4 and MKK7 are direct
activators of JNK (Haeusgen et al., 2009). JNK has more than 60 substrates, including
a variety of nuclear transcription factors such as c-Jun, ATF2, and Elk-1, as well as
cytoplasmic substrates such as cytoskeletal proteins and mitochondrial proteins like
Bcl-2 and Bcl-xl (Antoniou and Borsello, 2012).
JNK has most often been studied in the context of cellular stress and
apoptosis related to heat shock or DNA damage (Kyriakis and Avruch, 2001;
Reinecke et al., 2013). In the nervous system, JNK plays an important role in synaptic
plasticity, neuronal regeneration, and brain development (Tararuk et al., 2006;
Waetzig et al., 2006). Evidence has also suggested that JNK activity is involved in the
regulation of the post-synaptic density protein called post-synaptic density-95 (PSD95) (Kim et al., 2007). Interactions between GPER and PSD-95 have been identified
in hippocampal dendritic spines (Akama et al., 2013), suggesting a possible link
between JNK and GPER at the synaptic membrane. Much less is known, however,
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about JNK’s role in learning and memory. Studies of JNK inhibitor-treated mice
suggest a facilitative role of JNK activation in long-term inhibitory avoidance
memory and neuroprotective effects in hippocampal neurons (Bevilaqua et al., 2007;
Carboni et al., 2008). In addition, a study using JNK1-deficient (JNK1-/-) mice found
that JNK1 may play a crucial role in short-term synaptic plasticity and mGluRdependent long-term depression (Li et al., 2007). However, other data indicate that
JNK inhibition in the hippocampus enhances short-term memory (Bevilaqua et al.,
2003), suggesting that JNK may also negatively regulate memory. Therefore, the role
of JNK signaling in hippocampal memory formation is unclear. Furthermore, nothing
is known about whether JNK signaling is involved estrogenic regulation of the
hippocampus or memory. As such, the role of JNK in mediating the effects of E2 or
GPER on memory was of interest in this thesis.

Aims
Given the uncertainty surrounding the role of the putative mER GPER in memory
formation, the primary goals of this thesis were to pinpoint the role of GPER in
regulating hippocampal object recognition and spatial memory consolidation and
determine the molecular mechanisms underlying this regulation. To achieve these
goals, we conducted a series of studies in which we infused a GPER agonist or
antagonist directly into the DH of ovariectomized mice immediately after training in
the OR and OP tasks.. We found that GPER regulates both object recognition and
spatial memory consolidation, but that these effects were dependent on JNK, but not
ERK activation in the DH. Next, we found that the memory-enhancing effects of E2
were not dependent on JNK or GPER activation in the DH. Collectively, these data
suggest that GPER enhances hippocampal memory consolidation by activating
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different cell signaling cascades than E2. As such, GPER does not appear to function
as a mER in the hippocampus.
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Materials and Methods
Subjects
Subjects were female C57BL/6 mice (8-10 weeks of age) purchased from
Taconic Biosciences (Cambridge City, IN). After surgery, mice were singly housed in
a room with a 12-hour light/dark cycle, and were allowed ad libitum access to food
and water. All behavioral testing was performed between 9 am and 6 pm in a quiet
room with dim lights. All procedures were approved by the University of WisconsinMilwaukee Institutional Animal Care and Use Committee, and followed policies set
forth by the National Institutes of Health Guide for the Care and Use of Laboratory
Animals.

Surgery
At least one week prior to behavioral testing, mice were bilaterally
ovariectomized and implanted with chronic indwelling guide cannuale within the
same surgical session as previously described (Boulware et al., 2013; Fortress et al.,
2013b; Fortress et al., 2014). Mice were anesthetized with isoflurane gas (2%
isoflurane in 100% oxygen) and secured in a stereotaxic apparatus (Kopf Instruments).
Following ovariectomy, mice were implanted with guide cannulae (22 gauge, C232G,
Plastics One) into the DH (-1.7 mm AP, ±1.5 mm ML, -2.3 mm DV) or DH and

dorsal third ventricle (intracerebroventricular (ICV); -0.9 mm AP, ±0.0 mm ML, -2.3
mm DV) as previously performed (Boulware et al., 2013; Fortress et al., 2013b;

Fortress et al., 2014). Dummy cannulae (C232DC, Plastics One) were inserted into all
guide cannulae to preserve patency of the guide cannulae.

Cannulae were fixed to

the skull with dental cement (Darby Dental Supply) that served to close the wound.
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Mice were allowed 7 days to recover from surgery before the start of behavioral
testing.

Drugs and infusions
During infusions, mice were gently restrained and dummy cannulae were
replaced with an infusion cannula (C3131; DH: 28 gauge, extending 0.8 mm beyond
the 1.5 mm guide; ICV: 28 gauge, extending 1.0mm beyond the 1.8 mm guide)
attached to PE20 polyethylene tubing that was mounted on a 10 µl Hamilton syringe.
Infusions were controlled by a microinfusion pump (KDS Legato 180; KD Scientific).
All infusions were conducted immediately post-training at a rate of 0.5 µl/minute in
the DH or 1 µl/2 minutes into the dorsal third ventricle as described previously
(Boulware et al., 2013; Fortress et al., 2013b; Fortress et al., 2014). Infusion cannulae
remained in place for 1 min after each infusion to prevent diffusion back up the
cannula track. For studies in which E2 or G-1 was administered in combination with
G-15 or a cell-signaling inhibitor, the antagonist or cell-signaling inhibitor was first
infused bilaterally into the DH and then E2 or G-1 was infused ICV immediately
afterwards. We routinely use this triple infusion protocol to prevent possible tissue
damage from two DH infusions in rapid succession (Fernandez et al., 2008; Fan et al.,
2010; Zhao et al., 2010; Zhao et al., 2012; Boulware et al., 2013; Fortress et al.,
2013b). This protocol allows us to infuse estrogenic compounds adjacent to the DH
while inhibiting receptor or cell-signaling activation directly within the DH.
G-1, 1-[4-(6-bromobenzo[1,3]dioxol-5yl)-3a,4,5,9b-tetrahydro-3Hcyclopenta [c]quinolin-8-yl]-ethanone (Azano biotech) was dissolved in 16%
dimethylsulfoxide (DMSO) and infused at doses of 2 or 4 ng/hemisphere into the DH
or 8 ng ICV. G-1 is a selective agonist for GPER that does not bind ERα and ERβ at
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concentrations up to 10 µM in vitro (Bologa et al., 2006; Blasko et al., 2009). The
vehicle control for G-1 was 16% DMSO in 0.9% saline. G-15, (3aS*,4R*,9bR*)-4-(6Bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta[c]quinoline (Azano biotech)
was dissolved in 2% DMSO and infused at doses of 1.85, 3.7, and 7.4 ng/hemisphere
into the DH. G-15 is selective antagonist for GPER that also does not bind to ERα
and ERβ at concentrations up to 10 µM in vitro (Dennis et al., 2009). The vehicle
control for G-15 was 2% DMSO in 0.9% saline.
Cyclodextrin-encapsulated E2 (Sigma-Aldrich) was dissolved in 0.9% saline
and infused at doses of 5 µg/hemisphere into the DH or 10 µg ICV (Zhao et al., 2012;
Boulware et al., 2013). The vehicle control for E2 was 2-hydroxypropyl-βcyclodextrin (HBC, Sigma-Aldrich), dissolved in 0.9% saline using the same amount
of cyclodextrin as E2 for infusions. The JNK inhibitor SP600125 (Anthra[1,9cd]pyrazol-6(2H)-one, Sigma-Aldrich) was dissolved in 2% DMSO and infused at
doses of 0.11, 0.55, and 2.75 ng/hemisphere into the DH. SP600125 is a selective
inhibitor for JNK that does not affect ERK and p38 at concentrations below 10 µM
(Bennett et al., 2001). The vehicle control for SP600125 was 2% DMSO in 0.9%
saline. The MEK inhibitor U0126 (1,4-diamino-2,3-dicyano-1,4-bis (oaminophenylmercapto) butadiene, Promega) was dissolved in 25% DMSO and
infused at a dose of 0.5 µg/hemisphere into the DH. This dose does not impair OR and
OP memory by itself (Fernandez et al., 2008; Boulware et al., 2013), and therefore,
any effects of this drug in combination with E2 or G-1 cannot be attributed to a
general memory impairing effect of this compound. The vehicle control for U0126
was 25% DMSO in 0.9% saline.

Object recognition and object placement
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OR and OP were conducted to examine hippocampus-dependent object
recognition and spatial memory. Both tasks have been shown to involve dorsal
hippocampal function (Baker and Kim, 2002; Luine et al., 2003; Frye et al., 2007;
Cohen et al., 2013) and are sensitive to E2 treatment (Gresack and Frick, 2006; Zhao
et al., 2010). Before the start of behavioral training, mice were handled (1 min/day)
for three days to acclimate them to the experimenters. They were also familiarized
with objects by placing a small Lego not used during testing in their home cage. At
the start of training, mice were habituated to the empty white arena (width, 60 cm;
length, 60 cm; height, 47 cm) by allowing them to explore for five min/day for two
consecutive days. On third day, mice were habituated for two minutes in the arena,
and then placed in a holding cage while two identical objects were placed near the
northwest and northeast corners of the arena. Mice were then returned to the arena
and allowed to freely explore the objects until they accumulated 30 s of investigation.
Immediately after this training, mice were infused and then returned to their home
cage. After 24 or 48 h, memory was tested by allowing mice to accumulate 30 s
exploring a novel object and an object identical to the familiar training objects. Time
spent with the objects was recorded using by ANYmaze tracking software (Stoelting).
Because mice inherently prefer novelty, mice who remember the familiar object spend
more time investigating the novel object than chance (15 s). Vehicle-infused mice do
not remember the familiar object 48 h after training (Gresack et al., 2007), so we used
this delay to test the memory enhancing effects of E2 and G-1. However, vehicleinfused females do remember the familiar object 24 h after training (Gresack et al.,
2007), so this shorter delay was used to test for potential memory impairing effects of
G-15 and cell-signaling inhibitors.
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The OP task used the same apparatus and general procedure as OR, but
instead of substituting a novel object for a training object during testing, one familiar
object was moved to the Southeast or Southwest corner of the testing arena. Because
vehicle-infused females remember the original object placement after 4 h, but not 24
h(Boulware et al., 2013), we used the 24-h delay to test memory enhancing effects of
E2 and G-1 and the 4-h delay to test memory impairing effects of G-15 and cellsignaling inhibitors. Two weeks separated OR and OP testing to allow acute effects of
the drug infusions to dissipate prior to the next infusion (n = 6-12/group).

Western blotting
Western blotting was performed as described previously (Fernandez et al.,
2008; Boulware et al., 2013). To determine the effects of G-1 on DH cell signaling,
mice were cervically dislocated and decapitated, and the dorsal hippocampus was
dissected bilaterally 5, 15, or 30 min after infusion and stored at -80°C until
homogenization. To determine the effects of E2, GPER compounds, and cell-signaling
inhibitors on DH cell signaling, the DH was dissected bilaterally 5 min after infusion.
DH tissues were resuspended 50 µl/mg in lysis buffer and homogenized by sonication
(Branson Sonifier 250). Proteins were then electrophoresed on 10% Tris-HCl precast
gels (Bio-Rad) and transferred to PVDF membranes (Bio-Rad). Western blots were
blocked with 5% skim milk and incubated with primary antibodies (phospho-ERK,
phospho-Akt, phospho-PI3K, phospho-JNK, and phospho-ATF2, 1:1000; Cell
Signaling Technology) overnight. Blots were then incubated with the appropriate
HRP-conjugated secondary antibody (1:5000; Cell Signaling), and developed using
West Dura chemiluminescent substrate (Pierce). A ChemiDocMP gel imager (Bio-Rad)
was used for signal detection of protein expression. Densitometry was performed
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using Carestream Molecular Imaging Software (Carestream Healthcare). Blots then
were stripped with 0.2M NaOH and incubated with antibodies (total-ERK, total-Akt,
total-PI3K, and total-JNK, 1:1000; β-actin, 1:5000; Cell Signaling Technology) for
protein normalization. Data were represented as immunoreactivity percent of vehicle
controls. Treatment effects were measured within single gels (n = 5-8/group).

Statistics
For OR and OP data, one-sample t-tests were conducted using SPSS (IBM,
Armonk, NY) to determine if each group spent more time than chance (15 s)
exploring the novel or moved object (Gresack and Frick, 2003). Western blotting data
were analyzed in GraphPad Prism 6 (La Jolla, CA) using one-way ANOVA followed
by Fisher’s LSD posthoc tests and selected t-tests . Significance was determined at p
< 0.05.
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Results
GPER regulates hippocampal memory consolidation
We first infused the GPER agonist G-1 into the DH to determine if activation
of GPER in the DH enhances object recognition and object placement memory
consolidation in a manner similar to E2. Mice received bilateral DH infusion of
vehicle (16% DMSO) or on of two doses of G-1 (2 or 4 ng/hemisphere) immediately
after OR training. Forty-eight hours later, mice infused with vehicle of 2 ng G-1 spent
no more time with the novel object than chance (15 s). In contrast, mice infused with
4 ng/hemisphere of G-1 spent more time exploring the novel object than chance (t(8) =
2.56, p = 0.03; Fig.1A), suggesting that 4 ng G-1 enhanced object recognition
memory consolidation. Two weeks after OR testing, mice were trained in OP and then
were immediately infused with vehicle, 2 ng G-1, or 4 ng G-1. Twenty-four hours
later, mice infused with vehicle or 2 ng G-1 did not exhibit a preference for the moved
object. However, as in OR, mice receiving 4 ng/hemisphere of G-1 spent significantly
more time than chance with the moved object (t(9) = 3.81, p = 0.004; Fig. 1B),
demonstrating enhanced spatial memory consolidation.
Because these data suggest that activation of GPER facilitates hippocampal
memory consolidation, we next examined effects of GPER antagonism on memory
consolidation. Immediately after OR or OP training, mice received bilateral DH
infusion of vehicle (2% DMSO) or one of three doses of G-15 (1.85, 3.7, or 7.4
ng/hemisphere). Mice receiving vehicle (t(8) = 3.52, p = 0.008) or 1.85 ng/hemisphere
of G-15 (t(7) = 3.32, p = 0.013) showed preference for the novel object 24 h after OR
training suggesting intact object recognition memory after treatment with a low dose
of G-15. In contrast, mice receiving 3.7 (t(8) = 2.02, p = 0.08) or 7.4 (t(6) = 0.89, p =
0.41) ng/hemisphere of G-15 did not (Fig. 1C), suggesting that these doses impaired
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Figure 1. GPER activation enhances OR and OP memory consolidation. A, Mice receiving DH
infusion of 4 ng/hemisphere G-1 (but not vehicle or 2 ng G-1) spent more time than chance
(dashed line at 15 s) with the novel object 48 hr after training, indicating enhanced memory for
the familiar object (n = 6-9/group). B, Similarly, mice infused with 4 ng G-1, but not vehicle or 2
ng G-1, spent significantly more time with the moved object than chance 24 h after OP training,
indicating enhanced spatial memory (n = 9-10/group). C, Mice receiving 3.7 or 7.4
ng/hemisphere G-15 exhibited impaired OR memory consolidation 24 h after DH infusion,
whereas mice receiving vehicle or 1.85 ng G-15 did not (n = 7-9/group). D, In OP, 7.4 ng G-15
impaired spatial memory consolidation 4 h after DH infusion, but no other dose of G-15 affected
memory (n = 6-9/group). E, F, ICV infusion of 4 ng/hemisphere G-1 significantly enhanced
OR (E) and OP (F) memory tested 48 h and 24 h after infusion, respectively (n = 8-11/group)..
However, DH infusion of 1.85 ng/hemisphere G-15 abolished these effects, suggesting that
activation of GPER is necessary for G-1-mediated hippocampal memory enhancement. Each bar
represents the mean ± SEM time spent with the novel or moved object (*p < 0.05, **p < 0.01
relative to chance)..
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object recognition memory consolidation. In OP, mice receiving DH infusion of
vehicle (t(8) = 2.62, p = 0.03), 1.85 ng G-15 (t(7) = 3.32, p = 0.013), or 3.7 ng G-15 (t(8)
= 2.02, p = 0.08) spent significantly more time than chance (15 s) with the moved
object, whereas mice infused with 7.4 ng G-15 did not (Fig. 1D). That only the high
dose of G-15 impaired spatial memory consolidation suggests that spatial memory
may be less sensitive to the effects of G-15 antagonism. that 1.85 ng/hemisphere of G15 did not impair memory consolidation on its own and GPER inhibition impairs
hippocampal memory although the sensitivity of task is a little bit different.
Finally, to confirm that G-15 acts as a GPER antagonist, we examined
whether G-15 could block the memory-enhancing effects of G-1. To this end, we
infused 8 ng G-1 into the dorsal third ventricle because bilateral infusion of 4
ng/hemisphere G-1 enhanced memory in both tasks. We also infused 1.85 ng/
hemisphere G-15 into the DH because this dose had no detrimental effects on memory
in both tasks. Immediately after training in each task, mice received a DH infusion of
vehicle (2% DMSO) or G-15 (1.85 ng/hemisphere) followed immediately by an ICV
infusion of vehicle (16% DMSO) or G-1 (8 ng). OR and OP retention were tested 48
and 24 hours later, respectively. In both tasks, G-15 blocked the memory enhancing
effects of G-1 (Fig. 1E,F). Only mice receiving G-1 + vehicle showed a significant
preference for the novel object (t(7) = 2.68, p = 0.032; Fig 1E) and moved object (t(8) =
2.46, p = 0.04; Fig 1F). These results demonstrate that GPER activation is necessary
for G-1 to enhance hippocampal memory consolidation in female mice, and suggest
that GPER regulates both object recognition and spatial memory consolidation.

G-1 does not activate ERK or PI3K/Akt signaling in the DH
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We have previously shown that the enhanced memory consolidation
induced by DH infusion of E2 or agonists of ERα and ERβ is dependent on DH p42
ERK phosphorylation (Fernandez et al., 2008; Boulware et al., 2013). To determine
whether GPER also enhances memory by activating p42 ERK, we first measured the
effects of GPER activation on ERK phosphorylation. Mice received bilateral DH
infusion of 4 ng G-1 and the DH was dissected bilaterally 5, 15, or 30 min later.

Figure 2. GPER does not activate the ERK or PI3K/Akt signaling pathways. A, G-1 (4
ng/hemisphere) infusion did not increase DH p42 and p44 ERK phosphorylation relative to
vehicle 5, 15, or 30 min after DH infusion. B, G-1 infusion significantly reduced Akt
phosphorylation levels in the DH 30 min after infusion. C, G-1 infusion did not alter PI3K
phosphorylation relative to vehicle 5, 15, or 30 min after DH infusion. Each bar represents the
mean ± SEM percent change from vehicle controls (*p < 0.05 relative to vehicle). Insets are
representative Western blots. (n = 5/group).
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In contrast to E2(Fernandez et al., 2008; Boulware et al., 2013), G-1 infusion did not
significantly increase levels of phospho-p42 ERK at any time point examined (F(3,16)
= 0.72; Fig. 2A). G-1 also did not affect levels of phospho-p44 ERK (F(3,16) = 3.07;
Fig. 2A). We then examined activation of the PI3K/Akt signaling pathway because we
have previously demonstrated that activation of this signaling pathway is necessary
for E2 to activate ERK and enhance OR memory consolidation in young and middleaged female mice (Fan et al., 2010; Fortress et al., 2013b). However, G-1 did not
significantly increase levels of phospho-Akt (F(3,16) = 3.94, p > 0.05; Fig. 2B) or
phospho-PI3K (F(3,16) = 0.68; p > 0.05; Fig. 2C). In fact, G-1 decreased levels of
phospho-Akt 30 min after infusion (Fig. 2B). Collectively, these data show that GPER
activation does not activate ERK or PI3K/Akt signaling in the DH and suggest that
the effects of GPER activation on DH cell signaling are different from those of E2 or
ER agonists.

GPER activation leads to rapid JNK phosphorylation in the DH
We next investigated whether GPER activation could phosphorylate c-Jun
N-terminal Kinase (JNK) in the DH. As a seven transmembrane domain receptor,
GPER is comprised of heterotrimeric G protein subunits Gαβγ (Filardo and Thomas,
2005), and the Gβγ-subunit plays a role in activating protein kinase cascades such as
ERK and JNK (Luttrell et al., 1999; Filardo and Thomas, 2005; Goldsmith and
Dhanasekaran, 2007). Moreover, JNK is known to play an important role in synaptic
plasticity, neuronal regeneration, and brain development (Tararuk et al., 2006;
Waetzig et al., 2006). Therefore, we thought it possible that GPER might activate one
or both of the two JNK isoforms (p46 and p54). Mice bilaterally infused into the DH
with vehicle or 4 ng G-1 exhibited a significant increase in the phosphorylation of
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Figure 3. GPER activation increases JNK phosphorylation in the DH. A,B, DH infusion of G-1 (4
ng/hemisphere) significantly increased phosphorylation of the JNK p46 isoform (A) and p54
isoform (B) within 5 min. Levels returned to baseline 15 min later. C, Similarly, G-1 infusion
significantly increased phosphorylation of the downstream JNK transcription factor ATF2 in the
DH 5 min after infusion. (n = 5/group).

both the p46 (F(3,16) = 13.46, p < 0.001; Fig. 3A) and p54 (F(3,16) = 6.335, p < 0.01; Fig.
3B) isoforms of JNK 5 min after infusion. These effects were transient, as levels of
both phosphorylated isoforms returned to baseline by 15 min after infusion. We next
examined phosphorylation of the downstream JNK transcription factor called
activating transcription factor 2 (ATF2) (Antoniou and Borsello, 2012). As with JNK,
G-1 infusion significantly increased levels of, phospho-ATF2 5 min after DH infusion
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(F(3,16) = 3.03, p < 0.05; Fig. 3C), and levels returned to baseline by 15 min after
infusion.
To confirm that the G-1 mediated-JNK activation observed occurred via
GPER activation, we next examined if G-15 could block the effects of G-1 on JNK

Figure 4. GPER antagonist blocks the G-1-mediated JNK phosphorylation in DH. A,B, ICV
infusion of 8 ng G-1 significantly increased levels of phosphorylated p46 JNK (A) and p54 JNK (B)
5 min after infusion. However, these effects were abolished by DH infusion of G-15 indicating that
GPER activation is necessary for G-1 to activate JNK signaling. C, Neither G-1 nor G-15 altered
ERK phosphorylation. Each bar represents the mean ± SEM percent change from vehicle (*p <
0.05, **p < 0.01, ***p < 0.001). Insets are representative Western blots. (n = 6/group).

２８

activation. Mice received DH infusion of vehicle or G-15, and ICV infusion of
vehicle or G-1. Consistent with the effects of DH G-1 infusion, ICV infusion of G-1
increased phosphorylation of both the p46 (F(2,15) = 4.97, p < 0.05; Fig 4A) and p54
(F(2,15) = 7.89, p < 0.01; Fig 4B) isoforms of JNK 5 min after infusion. Infusion of G15 into the DH completely blocked these effects (Fig. 4A,B), suggesting that GPER
activation induces JNK phosphorylation in the DH. In contrast, ICV and DH infusion
of G-1 and G-15 did not significantly alter ERK phosphorylation (Fig. 4C).

Activation of JNK is necessary for GPER to influence hippocampal memory
consolidation
Given the rapid activation of JNK by G-1, we next examined whether this
activation is necessary for G-1 to enhance memory consolidation. To do so, we used
the JNK activation inhibitor SP600125. We first needed to find a dose of SP600125
that did not block memory consolidation on its own. Therefore, we infused mice with
vehicle (2% DMSO) or one of two doses of SP600125 (0.55 or 2.75 ng/hemisphere)
immediately after OR or OP training. Mice receiving vehicle (t(6) = 3.27, p = 0.02) or
either dose of SP600125 (0.55 ng, t(5) = 2.7, p = 0.043; 2.75 ng, t(7) = 3.46, p = 0.01)
spent significantly more time than chance with the novel object 24 h after OR training
(Fig. 5A), suggesting that neither dose of SP600125 impaired OR memory
consolidation. Similarly, mice infused with vehicle (t(8) = 3.87, p = 0.005) or either
dose of SP600125 (0.55 ng, t(9) = 3.45, p = 0.007; 2.75 ng, t(7) = 3.7, p = 0.008) spent
significantly more time than chance with the moved object 4 h after OP training (Fig.
5B), indicating neither dose impaired OP memory consolidation. Because neither dose
affected memory on its own, we selected the highest behaviorally ineffective dose of
SP600125 (2.75 ng/hemisphere) for our remaining studies.
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Figure 5. JNK inhibition blocks the GPER-mediated memory enhancement in DH. A, Mice
receiving DH infusion of vehicle or the JNK inhibitor SP600125 (0.55 or 2.75 ng/hemisphere) spent
significantly more time than chance with the novel object 24 hr after training, suggesting that
neither dose of SP600125 impaired memory on its own (n = 6-8/group). B, Similarly, neither dose
of SP600125 impaired OP memory tested 4 h after DH infusion (n = 6-10/group). C, D,
Immediately after OR or OP training, mice received DH infusion of vehicle, SP600125 (1.85
ng/hemisphere), or U0126 (0.5 µg/hemisphere) followed by ICV infusion of vehicle or G-1 (8 ng).
ICV infusion of G-1 significantly enhanced OR memory (C) and OP memory (D). SP600125
blocked these effects (C, D), but U0126 did not, suggesting that activation of JNK, but not ERK, is
necessary for GPER-mediated hippocampal memory enhancement (n = 7-10/group).. Each bar
represents the mean ± SEM time spent with the novel or moved object (*p < 0.05, **p < 0.01 , ***p
< 0.001 relative to chance).

To test whether activation of JNK or ERK was necessary for G-1 to enhance
memory consolidation, we next infused mice with G-1 plus 2.75 ng SP600125 or the
ERK activation inhibitor U0126 at a dose (0.5 µg/hemisphere) that has no effect on
OR or OP on its own (Fernandez et al., 2008; Boulware et al., 2013). A new set of
mice received DH infusion of vehicle (25% DMSO), 2.75 ng SP600125, or 0.5 µg
U0126 and ICV infusion of vehicle (16% DMSO) or 8 ng G-1 immediately after OR
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Figure 6. JNK inhibition blocks the GPER-mediated cell signaling in DH. A, B, ICV infusion of 8
ng G-1 increased phosphorylation of p46 JNK (A) and p54 JNK (B) 5 min later. These effects were
blocked by DH SP600125 infusion. C, Neither G-1 nor SP600125 altered ERK phosphorylation (n
= 7-8/group).

and OP training. Memory in OR and OP was tested 48 and 24 hours later, respectively.
In both tasks, SP600125, but not U0126, blocked the memory-enhancing effects of G1 (Fig. 5C,D). Mice receiving G-1 + vehicle showed a significant preference for the
novel object (t(9) = 2.48, p = 0.04) and moved object (t(6) = 6.37, p = 0.0007), whereas
mice receiving G-1 + SP600125 did not (novel object, t(8) = 1.16, p = 0.28; moved
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Figure 7. ERK inhibition does not alter the GPER-mediated cell signaling in DH. A, B, The increase
in p46 (A) and p54 (B) phosphorylation induced by ICV infusion of 8 ng G-1 was not blocked by
DH U0126 infusion. C, Neither G-1 nor the behaviorally subeffective dose of U0126 altered ERK
phosphorylation. Each bar represents the mean ± SEM percent change from vehicle (*p < 0.05, **p
< 0.01). Insets are representative Western blots (n = 7-8/group).

object, t(7) = 0.86, p = 0.42), suggesting that JNK activation is necessary for G-1 to
enhance memory consolidation. In contrast, mice infused with G-1 + U0126 spent
significantly more time than chance with the novel object (t(8) = 2.83, p = 0.02) and
moved object (t(10) = 2.48, p = 0.03), suggesting that ERK activation is not necessary
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for G-1 to enhance memory consolidation. We next examined the effects of JNK and
ERK inhibition on G-1 mediated hippocampal cell signaling. Consistent with the
behavioral data, ICV infusion of G-1 increased phosphorylation of both p46 JNK
(F(2,19) = 6.56, p < 0.01; Fig. 6A) and p54 JNK (F(2,19) = 6.47, p < 0.01; Fig. 6B) 5 min
after infusion. DH infusion of SP600125 abolished the effects of G-1 on p46 and p54
JNK (Fig. 6A,B). In contrast, G-1 and SP600125 did not significantly alter ERK
phosphorylation (Fig. 6C). Unlike SP600125, U0126 did not block the GPERmediated JNK activation (Fig. 7A,B). Whereas G-1 increased phosphorylation of both
p46 JNK (F(2,15) = 4.44, p < 0.05; Fig. 7A) and p54 JNK (F(2,15) = 6.68, p < 0.01; Fig.
7B) 5 min after infusion, U0126 did not block the effects of G-1 on p46 JNK (t(10) =
2.35, p < 0.05; Fig. 4H) and p54 JNK (t(10) = 2.34, p < 0.05; Fig. 7B). Moreover,
neither G-1 nor U0126 infusion altered ERK activation (Fig. 7C). These data suggest
that ERK activation does not regulate G-1-induced hippocampal JNK activation.
Together, these results support that activation of JNK, but not ERK, is essential for
GPER to induce memory enhancement.

E2-mediated hippocampal memory consolidation is independent of GPER and
JNK activation
We have previously demonstrated that E2 enhances hippocampal memory
consolidation by ERα− or ERβ-mediated ERK activation in the DH (Fernandez et al.,
2008; Boulware et al., 2013). In contrast, above data support that the G-1-induced
enhancement of hippocampal memory consolidation is dependent on hippocampal
JNK activation, rather than ERK activation. This finding begs the question of whether
E2-induced memory enhancements are also dependent on JNK and/or GPER
activation. To address this issue, we first examined the effects of E2 on JNK cell
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signaling in the DH. Mice received bilateral DH infusion of the vehicle or E2 (5 µg/
hemisphere), and the DH was dissected bilaterally 5 or 10 min later. DH E2 infusion
did not alter DH p46 JNK, and p54 JNK phosphorylation at either the 5 or 10 min
time point (Fig. 8A,B), suggesting that E2 does not activate JNK in the DH. As our
previous studies (Fernandez et al., 2008; Boulware et al., 2013), DH E2 infusion

Figure 8. E2 increases activation of ERK, but not JNK, in the DH. A, B, DH infusion of E2 (5
µg/hemisphere) did not alter levels of phospho-p46 JNK (A) or phospho-p54 JNK (B) 5 or 10 min
later. C, DH infusion of E2 (5 µg/hemisphere) significantly increased phosphorylation of p42
ERK, but not p44 ERK, 5 min after infusion. Levels returned to baseline 10 min later. Each bar
represents the mean ± SEM percent change from vehicle controls (*p < 0.05). Insets are
representative Western blots. (n = 6/group).
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increased phospho-p42-ERK 5 min after infusion (F(2,15) = 3.38, p < 0.05; Fig. 8C) but
had no effect on p44 ERK (Fig. 8C). These data suggest that E2 increases activation of
ERK, but not JNK, in the DH.
Next, we investigated the effects of GPER and JNK inhibition on E2mediated hippocampal cell signaling. Mice received ICV and DH infusions,
respectively, of vehicle + vehicle, E2 + vehicle, E2 + SP600125, or E2 + G-15, and DH
tissue was collected 5 min later. As in our previous work (Boulware et al., 2013), ICV
infusion of E2 increased levels of phospho-p42 ERK (F(3,20) = 7.6, p < 0.01), but not
phospho-p44 ERK (F(3,20) = 0.7, p > 0.05) (Fig. 9A). The increase in p42 ERK was
not blocked by DH infusion of G-15 and SP600125 (G-15, F(3,20) = 7.6, p < 0.001;
SP600125, F(3,20) = 7.6, p < 0.05; Fig. 9A). As with DH infusion, ICV infusion of E2
did not alter phosphorylation of p46 JNK or p54 JNK, whether alone or in
combination with DH infusion of G-15 and SP600125 (Fig. 9B,C). Together, these
data reiterate that E2 does not rapidly activate JNK in the DH and indicate that
activation of JNK or GPER is not necessary for E2 to activate ERK in the DH.
Given this finding, the next logical step was to determine whether JNK and
GPER activation play a role in E2-mediated hippocampal memory enhancement. To
do so, we infused mice with vehicle, G-15 (1.85 ng/hemisphere) or SP600125 (2.75
ng/hemisphere) into the DH and vehicle or E2 (10 µg) into the dorsal third ventricle
immediately after OR and OP training. OR and OP retention were tested 48 and 24
hours later, respectively. In both tasks, mice receiving E2 + vehicle showed a
significant preference for the novel object (t(5) = 2.73, p = 0.04; Fig 9D) and moved
object (t(7) = 2.69, p = 0.03; Fig 9E), in agreement with our previous work (Boulware
et al., 2013). Consistent with the lack of JNK activation observed above, SP600125
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Figure 9. GPER and JNK inhibition do not affect the E2-mediated memory enhancement and cell
signaling in the DH. A, ICV infusion of E2 (10 µg) increased phospho-p42 ERK levels 5 min after
infusion; this effect was not blocked by DH infusion of G-15 or SP600125. ICV infusion of E2 (10
µg) did not alter p44 ERK phosphorylation (n = 6/group). B, C, ICV infusion of E2 did not alfter
p46 JNK (B) or p54 JNK (C) phosphorylation 5 min after infusion when infused with vehicle, G15, or SP600125 phosphorylation (n = 6/group). Each bar represents the mean ± SEM percent
change from vehicle (*p < 0.05, **p < 0.01, ***p < 0.001). Insets are representative Western
blots. D, E, Immediately after OR or OP training, mice received DH infusion of vehicle, G-15
(1.85 ng/hemisphere), or SP600125 (2.75 ng/hemisphere) followed by ICV infusion of vehicle or
E2 (10 µg). ICV infusion of E2 significantly enhanced OR memory (D) and OP memory (E), and
these effects were not blocked by G-15 or SP600125 (D, E), suggesting that neither GPER nor
JNK activation is necessary for E2 to enhance hippocampal memory consolidation (n = 612/group). Each bar represents the mean ± SEM time spent with the novel or moved object (*p <
0.05 relative to chance).
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did not prevent E2 from enhancing OR or OP memory consolidation (Fig. 9D,E), as
mice receiving E2 + SP600125 spent significantly more time with the novel object
(t(11) = 2.36, p = 0.04) and moved object (t(9) = 2.45, p = 0.04). Interestingly, G-15 also
did not block E2-induced memory enhancements in either task (Fig. 9D,E), as
demonstrated by the fact that mice receiving E2 + G-15 spent significantly more time
with the novel object (t(5) = 3.67, p = 0.01) and moved object (t(6) = 3.36, p = 0.02).
These results suggest that neither JNK nor GPER activation in the DH is necessary for
E2 to enhance hippocampal memory consolidation.
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Discussion
The present study provides the first evidence that GPER, a putative estrogen
receptor, regulates hippocampal memory consolidation in young ovariectomized
female mice in an E2-independent manner. This conclusion is supported by several
novel findings. First, GPER activation in the DH enhances OR and OP memory
consolidation and increases JNK, but not ERK, phosphorylation in the DH. Second,
the memory-enhancing effects of GPER activation are blocked by inhibition of JNK,
but not ERK, in the DH. Finally, E2 infusion increases ERK, but not JNK
phosphorylation in the DH, and the memory-enhancing effects of E2 are blocked by
inhibition of ERK, but not JNK or GPER activation. Collectively, these data indicate
that E2 enhances hippocampal memory consolidation in females by activating ERK,
whereas GPER enhances hippocampal memory consolidation by activating JNK. As
such, the data suggest that GPER in the DH does not function as an estrogen receptor
to facilitate memory consolidation.
Our findings showing that G-1 enhanced OR and OP memory consolidation
are consistent with previous studies demonstrating that systemic injections of G-1
enhanced spatial learning and memory in ovariectomized rats (Hammond et al., 2009;
Hammond and Gibbs, 2011; Hawley et al., 2014). However, the rat data do not permit
definitive conclusions about the role of hippocampal GPER in memory because
systemic treatments do not specifically affect the hippocampus. Therefore, we used
dorsal hippocampal infusions of G-1 to pinpoint the role of hippocampal GPER in
regulating memory consolidation. To ensure that the effects of G-1 were specific to
GPER, we tested whether G-15 could antagonize the effects of G-1, as some studies
have indicated that G-1 can act in a GPER-independent manner. For example, in
breast cancer cell lines, G-1 has been found to interact with an ER-α variant, ER- α
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36, but not with GPER (Kang et al., 2010). Additionally, G-1 suppressed the
proliferation of ovarian and breast cancer cells, whereas GPER siRNA or G15 did not
attenuate the effects of G-1, suggesting that G-1 can act in a GPER-independent
manner in cancer cell lines (Wang et al., 2012). In contrast to these proliferative cells,
we found that G-15 infusion into the DH prevented G-1 from enhancing OR and OP
memory consolidation, as well as increasing JNK phosphorylation. These data suggest
that the effects of G-1 on memory and JNK activation are mediated by GPER in the
hippocampus. Interestingly, although higher doses of G-15 on their own impaired
both OR and OP memory consolidation, OP appeared to be a bit more sensitive to G15 than OR at the doses tested. Nevertheless, our finding that post-training DH
infusion of G-15 dose-dependently impaired memory consolidation is consistent with
previous data showing that chronic systemic treatment with G-15 dose-dependently
impaired spatial working memory in ovariectomized rats (Hammond et al., 2012).
Together, these data suggest an important role of GPER in hippocampal memory
processes.

The role of ERK in GPER-mediated memory enhancement
The molecular mechanisms through which GPER influences hippocampal
memory have not been investigated previously. Therefore, one of the primary goals of
this thesis was to pinpoint possible downstream effectors of GPER activation in the
mouse hippocampus. Based on our previous findings showing that p42 ERK
activation is necessary for E2 and agonists of ERα and ERβ to enhance OR and OP
memory (Fernandez et al., 2008; Boulware et al., 2013), our initial hypothesis was
that p42 ERK phosphorylation would also be necessary for G-1 to enhance memory.
This hypothesis was also supported by other studies showing that activation of GPER
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can activate the ERK pathway in pancreatic beta cells and the ERK activation effect is
removed in GPER knockout mice model and in GPER depletion model by small
interfering RNA (Maggiolini and Picard, 2010; Sharma and Prossnitz, 2011). We first
showed that G-1 does not affect p42 or p44 ERK phosphorylation in the DH 5, 15, or
30 min after infusion. These time points were selected based on our previous studies
demonstrating that DH E2 infusion increases p42 ERK phosphorylation 5 min after
DH infusion (Fernandez et al., 2008; Boulware et al., 2013; Fortress et al., 2013b). G1 has a slightly slower effects on the rapid mobilization of intracellular calcium (t1/2 ≈
30 s) than E2 (t1/2 ≈ 2 s) (Bologa et al., 2006), and it may take longer for G-1 to
activate ERK than E2. Therefore, we included the 15 and 30 min time points as well
as 5 min time point. However, G-1 infusion did not alter ERK activation at any time
point. This finding is consistent with data from vascular smooth muscle cells showing
that E2, but not GPER, increases ERK phosphorylation in these cells (Ortmann et al.,
2011).
To further explore possible effects of G-1 on ERK signaling, we measured
whether G-1 regulated activation of PI3K and Akt, based on our previous finding that
phosphorylation of PI3K/Akt signaling is necessary for E2 to activate ERK in the DH
and enhance OR memory consolidation (Fan et al., 2010; Fortress et al., 2013b).
Moreover, several studies show that GPER can regulate Akt cell signaling in
numerous cell lines (Moriarty et al., 2006; Maggiolini and Picard, 2010) and in rats
(Jang et al., 2013). As with ERK, however, we found that DH infusion of G-1 did not
increase PI3K or Akt phosphorylation at any time point. Indeed, Akt phosphorylation
was decreased 30 min after infusion, the reason for which is unclear. Nevertheless, the
fact that G-1 did not increase PI3K and Akt phosphorylation in the DH as observed
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after E2 infusion indicates that G-1 does not activate multiple aspects of ERK
signaling in the female mouse DH.
These data led us to hypothesize that ERK activation would not play a role in
the ability of G-1 to enhance OR and OP memory consolidation. Consistent with this
hypothesis, we found that the ERK inhibitor U0126 did not prevent G-1 from
enhancing OR or OP memory consolidation. These results demonstrate for the first
time that ERK activation is not necessary for GPER to enhance hippocampal memory
consolidation in female mice. Although this finding is novel as it relates to memory, it
is consistent with reports from peripheral tissues showing that the ERK inhibitors
U0126 and PD98059 do not prevent G-1 from inducing endothelium-dependent
vasorelaxation in rat aorta (Jang et al., 2013) or DNA synthesis in human epithelial
cells (Holm et al., 2011). These few examples do not permit any general conclusions
about the role of ERK in mediating the cellular effects of GPER activation, the
present data provide evidence that ERK is not involved GPER-mediated memory
regulation.

The role of JNK in GPER-mediated memory enhancement
Given the unexpected lack of a role for ERK in GPER-induced memory
enhancement, we next sought to identify other signaling pathways through which
GPER may mediate memory consolidation. We focused on JNK signaling, since this
MAPK is activated by various G proteins (Goldsmith and Dhanasekaran, 2007) and is
involved in regulating synaptic plasticity (Tararuk et al., 2006; Waetzig et al., 2006;
Kim et al., 2007). We demonstrated that GPER activation led to rapid phosphorylation
of both JNK isoforms in the DH, an effect that was blocked by DH infusino of the
JNK inhibitor SP600125, but not the ERK inhibitor U0126. In addition, we found that
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G-1 increased phosphorylation of the downstream JNK transcription factor ATF2,
suggesting that the G-1 induced phosphorylation of JNK also activated nuclear
transcription. Importantly, we found that activation of JNK, but not ERK, in the DH is
necessary for GPER to faciliate memory consolidaion in both the OR and OP tasks.
As such, these data demonstrate that JNK activation, but not ERK activation, is
necessary for GPER enhance hippocampal memory consolidation.
Although JNK has been studied in the context of cellular stress and apoptosis
(Kyriakis and Avruch, 2001; Reinecke et al., 2013), JNK has also been shown to play
an important role in synaptic plasticity, neuronal regeneration, and development in the
central nervous system (Tararuk et al., 2006; Waetzig et al., 2006). However, its role
in learning and memory has been understudied, and existing data provide conflicting
results. For example, some studies suggest an important role of JNK activation in
long-term inhibitory avoidance memory and in short-term synaptic plasticity and
long-term depression (Bevilaqua et al., 2007; Li et al., 2007; Carboni et al., 2008).
However, other data indicate that JNK negatively regulates short-term memory in the
hippocampus (Bevilaqua et al., 2003). Duration of JNK activation may play an
important role in the resulting effects on memory, as suggested by data showing that
short-term JNK activation facilitates hippocampal memory and synaptic plasticity,
whereas prolonged JNK activation leads to memory deficits and neurodegeneration
(Sherrin et al., 2011). Although our findings cannot directly speak to the
inconsitencies in the JNK literature, our findings provide much needed additional
information on the role of JNK in hippocampal memory. These data suggest that JNK
is an essential mediator of GPER-induced memory modulation. However, as will be
discussed below, JNK appears to play no role in E2-induced memory modulation.
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The estrogen receptor that doesn't act like an estrogen receptor
Evidence that GPER is an estrogen receptor comes from data showing that E2
binds GPER with high affinity (Revankar et al., 2005; Moriarty et al., 2006; Prossnitz
et al., 2007). However, other studies suggest that GPER acts independently of E2. For
example, a study using endothelial cells from ERα/ERβ-deficient mice demonstrated
that E2 could not activate cAMP or ERK pathways, despite the presence of GPER
(Pedram et al., 2006) and cells, COS-7 and CHO (Chinese hamster ovary) cells,
transfected with GPER failed to signal in response to E2 (Otto et al., 2008). Another
study revealed that treatment with G-15 or downregulation of GPER expression with
GPER shRNA did not prevent E2-mediated apoptosis in rat aortic vascular endothelial
cells (Ding et al., 2014). Further, rapid extranuclear E2 signaling in breast cancer cells
involved only ERα and ERβ but not GPER (Madak-Erdogan et al., 2008), and the
neuroprotective effects of E2 on post ischemic injury are not dependent on GPER
(Lamprecht and Morrison, 2014). Moreover, some investigators insist that GPER is
not a true ER, but potentially has a collaborative role in mediating the biological
actions of estrogens (Levin, 2009). Such studies have stimulated extensive debate
about whether GPER acts as a true estrogen receptor (Langer et al., 2010).
The present study adds to the debate by showing that GPER and E2 do not
enhance memory via the same cell signaling mechanisms. As we have previously
shown, E2 and agonists of ERα and ERβ require ERK activation in the DH to enhance
OR and OP memory consolidation in ovariectomized female mice (Fernandez et al.,
2008; Boulware et al., 2013; Fortress et al., 2013b). However, the present study found
no role of ERK in the memory-enhancing effects of GPER. Furthermore, the present
study found that E2 did not phosphorylate either isoform of JNK at any time point
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examined, nor did the JNK inhibitor SP600125 prevent E2 from enhancing OR or OP
memory consolidation. These data demonstrate not only that E2 does not activate JNK
in the DH, but also that JNK activation is not necessary for E2 to enhance
hippocampal memory consolidation. Although these data provide strong support that
GPER and E2 independently regulate memory formation, more definitive evidence
comes from the fact that G-15 does not prevent E2 from enhancing either OR or OP
memory consolidation. These data demonstrate that GPER activation is not necessary
for E2 to enhance hippocampal memory consolidation, and suggest that GPER does
not function as an estrogen receptor in the dorsal hippocampus.

Although we cannot

presently rule out potential interactions between GPER and ERα or ERβ, we find this
possibility unlikely given how closely ER agonists mimic the effects of E2 on memory
and ERK signaling (Boulware et al., 2013).

Further studies and conclusion
The surprising finding that GPER does not act as an estrogen receptor in the
dorsal hippocampus begs the question of whether GPER directly interacts with ERα
or ERβ. On the basis of our data, we could first hypothesize that no such interactions
take place and that GPER is not an estrogen receptor, at least in the hippocampus. If
GPER does not work as estrogen receptor, the alternative natural ligand for GPER
might be aldosterone. Some studies have indicated that the potential role of
aldosterone in GPER activation in vascular smooth muscle cells (Brailoiu et al., 2013;
Gros et al., 2013), still it needs further investigation (Filardo and Thomas, 2012).
Although several studies assert that GPER acts independently of E2 (Pedram et al.,
2006; Otto et al., 2008; Ding et al., 2014), it is difficult to ignore the many other
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studies showing that E2 activates GPER (Revankar et al., 2005; Thomas et al., 2005;
Moriarty et al., 2006; Prossnitz et al., 2007; Langer et al., 2010). Therefore, an
alternative hypothesis is that the activation of intracellular ERs may inhibit GPER
activation. Thus, activation of either ERα or ERβ might be able to suppress GPER
activation because E2 has higher binding affinity on ERα and ERβ than GPER;
competitive radiometric binding assay showed the Kd value of E2 on ERα (0.30 nM)
and ERβ (0.90 nM) in human endometrial cancer (HEC-1) cells, and the Kd value of
E2 on GPER (3.0 nM) in human embryonic kidney (HEK)293 cells (Sun et al., 1999;
Thomas et al., 2005). To examine potential interactions between intracellular ERs and
GPER, we may be able to test whether ERα and ERβ antagonists block the effects of
G-1 on memory and JNK activation. We can also examine physical interactions
among the receptors using sucrose fractionation and co-immunoprecipitation (CoIP)
as we have described previously(Boulware et al., 2013) . Delineating such interactions
would provide important insight into how the intracellular ERs and GPER may
interact to regulate hippocampal memory.
Future studies could also better elucidate the role of JNK signaling in
hippocampal formation, based on our findings that GPER activation enhances
hippocampal memory via the JNK signaling pathway. Given how little is known
about the role of JNK in memory, one possible future direction would be to determine
the molecular mechanisms through which JNK affects hippocampal memory. Two
avenues of research may be particularly promising: 1) determining how JNK regulates
PSD-95 protein, and 2) identifying how JNK modulates gene expression. Because
interactions between GPER and PSD-95 have been identified in hippocampal
dendritic spines (Akama et al., 2013) and JNK kinase activity is involved in the
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regulation of the PSD-95 to recruit synaptic AMPA receptors (Kim et al., 2007), the
JNK-PSD-95 relationship is worthy of further study to elucidate how JNK affects
hippocampal memory. Physical interaction between JNK and PSD-95 can be
examined by Co-IP and JNK inhibition effect on PSD-95 expression can be tested by
western blot or PCR. JNK-mediated gene expression in the hippocampus would also
be interesting to examine because we showed that G-1 activated the JNK downstream
transcription factor, ATF-2. ATF-2 works as a transcription factor responding to nerve
growth factor in sympathetic neurons (Lau and Ronai, 2012), therefore, microarray
technique will provide potential target gene for ATF-2 in the hippocampus and the
gene expression will be confirmed by RT-PCR. If we find JNK-mediated changes in
gene expression, then it would be interesting to examine the epigenetic processes that
might regulate this expression. For example, our laboratory has demonstrated that
histone acetylation and DNA methylation are necessary for E2 to enhance OR memory
consolidation in ovariectomized female mice (Zhao et al., 2010; Zhao et al., 2012). In
addition, E2-induced histone H3 acetylation was dependent on ERK activation (Zhao
et al., 2010; Zhao et al., 2012), indicating that changes in histone acetylation are
triggered by cell signaling mechanisms. To our knowledge, JNK-induced regulation
of epigenetic processes has not been investigated, and so is an area ripe for
investigation.
In conclusion, the present study provides the first evidence that GPER
activation can enhance hippocampal memory consolidation in JNK dependent manner
and that E2-mediated memory enhancement is independent of GPER and JNK
activation. These results do not support a role for GPER in the memory-enhancing
effects of E2, although GPER activation has similar memory-enhancing effects as E2.
This interesting finding may have important implications for the future design of
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estrogen-based therapies for reducing the risk of age-related memory decline and
Alzheimer’s disease in women (Yaffe et al., 1998; Zandi et al., 2002). Therefore,
better understanding of GPER function could provide important opportunities for the
development of new therapies that would provide the cognitive benefits of estrogen
without potentially dangerous side effects.
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